Detalles de la búsqueda
1.
Comparative analysis of drug response and gene profiling of HER2-targeted tyrosine kinase inhibitors.
Br J Cancer
; 124(7): 1249-1259, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33473169
2.
Selective CK1α degraders exert antiproliferative activity against a broad range of human cancer cell lines.
Nat Commun
; 15(1): 482, 2024 Jan 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38228616
3.
Comparative biochemical kinase activity analysis identifies rivoceranib as a highly selective VEGFR2 inhibitor.
Cancer Chemother Pharmacol
; 91(6): 491-499, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37148323
4.
Multi-omics analyses of MEN1 missense mutations identify disruption of menin-MLL and menin-JunD interactions as critical requirements for molecular pathogenicity.
Epigenetics Chromatin
; 15(1): 29, 2022 08 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35941657
5.
Comparative kinase and cancer cell panel profiling of kinase inhibitors approved for clinical use from 2018 to 2020.
Front Oncol
; 12: 953013, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36185300
6.
Combined Cellular and Biochemical Profiling to Identify Predictive Drug Response Biomarkers for Kinase Inhibitors Approved for Clinical Use between 2013 and 2017.
Mol Cancer Ther
; 18(2): 470-481, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30381447
Resultados
1 -
6
de 6
1
Próxima >
>>